Nabriva Therapeutics Plc's ability to collect accounts receivable sequentially worsen to 3.39, indicating more challenging environment then in the first quarter 2023, but still, it is a far cry from any concerns. Nabriva Therapeutics Plc's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 108 days, from 107 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 546 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 3351 to 3371.

What is Receivable Turnover Ratio?
What is Nabriva Therapeutics Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBRV Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	-64.09 %	-4.52 %	-43.36 %	-17.59 %	6.78 %
Y / Y Revenue Change	-75.6 %	-5.36 %	14.15 %	3.28 %	11.5 %
Receivable Turnover Ratio (TTM)	3.39	3.41	3.41	2.91	2.73
NBRV's Total Ranking	# 3371	# 3351	# 3351	# 2834	# 2518
Accounts Receivable average collection period days	108	107	107	126	133
Seq. Receivable Change	-57.76 %	39.58 %	-39.22 %	0.22 %	12.3 %
Seq. Revenue Change	-70.45 %	-28.2 %	15.49 %	-0.41 %	14.6 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 186
Healthcare Sector	# 547
Overall Market	# 3371

Receivable Turnover Ratio Statistics
High	Average	Low
9.98	3.21	0.9
(Dec 31 2018)		(Sep 30 2020)

NBRV Company Profile • Back to NBRV Efficiency Comparisons • Compare NBRV Receivables Turnover Ratio to its Competitors

Financial Statements
Nabriva Therapeutics Plc's Accounts Receivable	$ 4 Millions	Visit NBRV's Balance sheet
Nabriva Therapeutics Plc's Sales TTM	$ 30 Millions	Visit NBRV's Income Statement
Sources of NBRV's Revenues		Visit NBRV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NBRV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NBRV's Growth Rates	NBRV's Roa	NBRV's Inventory Turnover Ratio	NBRV's Dividend Comparisons
NBRV's Profitability Ratios	NBRV's Roi	NBRV's Asset Turnover Ratio	NBRV's Dividend Growth
NBRV's Valuation Ratios	NBRV's Roe	NBRV's Financial Strength Ratios	NBRV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Neuroone Medical Technologies Corp	18.25	$ 1.279 Millions	$ 0.070 Millions
Qhslab Inc	18.25	$ 1.295 Millions	$ 0.071 Millions
Cue Health Inc	18.24	$ 251.027 Millions	$ 13.759 Millions
Anika Therapeutics Inc	18.00	$ 161.782 Millions	$ 8.990 Millions
Xoma Royalty Corporation	17.45	$ 4.032 Millions	$ 0.231 Millions
Clearside Biomedical Inc	17.12	$ 1.618 Millions	$ 0.095 Millions
Precigen Inc	16.81	$ 22.103 Millions	$ 1.315 Millions
Chemed Corporation	16.35	$ 2,187.099 Millions	$ 133.800 Millions
Inovio Pharmaceuticals Inc	16.34	$ 17.250 Millions	$ 1.056 Millions
China Health Industries Holdings Inc	16.15	$ 0.112 Millions	$ 0.007 Millions
Nektar Therapeutics	16.07	$ 87.741 Millions	$ 5.461 Millions
Nutriband Inc	15.67	$ 2.278 Millions	$ 0.145 Millions
Titan Pharmaceuticals Inc	15.53	$ 0.396 Millions	$ 0.026 Millions
Palvella Therapeutics Inc	15.36	$ 33.207 Millions	$ 2.161 Millions
Cano Health Inc	15.17	$ 2,978.861 Millions	$ 196.310 Millions
Patterson Companies Inc	14.80	$ 6,524.261 Millions	$ 440.919 Millions
Petvivo Holdings Inc	14.70	$ 0.976 Millions	$ 0.066 Millions
Invo Fertility Inc	14.58	$ 1.177 Millions	$ 0.081 Millions
Protalix Biotherapeutics inc	14.52	$ 67.463 Millions	$ 4.648 Millions
Rvl Pharmaceuticals Plc	14.22	$ 35.973 Millions	$ 2.531 Millions
C4 Therapeutics Inc	14.20	$ 16.031 Millions	$ 1.129 Millions
Arbutus Biopharma Corp	14.20	$ 23.535 Millions	$ 1.658 Millions
Thorne Healthtech Inc	14.18	$ 255.948 Millions	$ 18.044 Millions
Marizyme Inc	13.96	$ 0.485 Millions	$ 0.035 Millions
Arrowhead Pharmaceuticals Inc	13.94	$ 256.213 Millions	$ 18.375 Millions
23andme Holding Co	13.80	$ 295.656 Millions	$ 21.428 Millions
Solana Company	13.68	$ 0.845 Millions	$ 0.062 Millions
Corcept Therapeutics Inc	13.64	$ 428.153 Millions	$ 31.395 Millions
Ethema Health Corporation	13.49	$ 5.525 Millions	$ 0.410 Millions
Revance Therapeutics Inc	13.44	$ 186.401 Millions	$ 13.872 Millions

Date modified: 2026-09-08T15:11:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.